The UK government will invest £8.4 million in COVID-19 research projects to reveal more information that can be used to develop therapies and vaccines against the disease.
List view / Grid view
Filter the results
Researchers in Boston have repurposed their lab into a centre to test samples for COVID-19, releasing a blueprint of how to do so for other labs in the US.
A total of 21 COVID-19 research projects have been granted funding by the UK government, including vaccine and therapeutic development.
Drug Target Review rounds up the latest announcements regarding funding for research into COVID-19 treatments and vaccines.
At the beginning of March, US President Donald Trump pressed the pharmaceutical industry to “accelerate the development” of vaccines and therapies to contain the outbreak of the coronavirus pandemic. This article explores what is currently known about COVID-19 and potential treatments that are in the pipeline.
The National Drug Discovery Centre (NDDC) has opened in Australia, with support from the government to subsidise the screening of medicinal compounds.
The ABPI has outlined how the new immigration system in the UK will affect life science workers and businesses, emphasising the need for regular reviews to remain competitive.
Boris Johnson, the Prime Minister of the UK, has announced a new Global Talent visa for researchers and scientists which will fast track those in certain fields.
A new report shows that there is still a lack of female representation within the senior roles of the major pharmaceutical companies.
25 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Prokarium announced the award of funding from the UK governments for the development of three new vaccines against Zika, bacterial diarrhoea and plague...